Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New.
Condition: New.
Condition: New.
Published by Innsbruck ; Wien : Verlag Integrative Psychiatrie VIP, 1995
ISBN 10: 3851840100 ISBN 13: 9783851840100
Language: German
Seller: ANTIQUARIAT BÜCHERBERG Martin Walkner, Salzburg, Austria
First Edition
309 S. mit 29 Abb. u. 41 Tab. Blaue Glanz-Karton-Broschur, 24 cm. Schönes Exemplar ohne Gebrauchsspuren. - 10. Alpenländisches Psychiatrie-Symposium. - Mit Bibliographie, Anmerkungen. hm [Versand in die BRD mit Deutscher Post / Aus der Schweiz NUR Kreditkartenzahlung, keine Banküberweisung] Sprache: Deutsch. - Gewicht in Gramm: 800. - Psychologie. - Stichworte: Schizophrenie; Therapie; Aufsatzsammlung, Medizin, Psychologie, Psychiatrie, Psychotherapie, Psychoanalyse, Seele, Familientherapie. -.
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: As New. Unread book in perfect condition.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Condition: New. In.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Condition: New. In English.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: New.
Published by Stuttgart ; New York : Thieme Verlag;, 1991
ISBN 10: 3137608015 ISBN 13: 9783137608011
Language: German
Seller: books4less (Versandantiquariat Petra Gros GmbH & Co. KG), Welling, Germany
gebundene Ausgabe. Condition: Gut. VII, 223 S. ; Das hier angebotene Buch stammt aus einer teilaufgelösten wissenschaftlichen Bibliothek und trägt die entsprechenden Kennzeichnungen (Rückenschild, Instituts-Stempel.); leichte altersbedingte Anbräunung des Papiers; der Buchzustand ist ansonsten ordentlich und dem Alter entsprechend gut. Sprache: Deutsch Gewicht in Gramm: 575.
Condition: New. pp. 159.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: New.
Condition: New. pp. 150.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: As New. Unread book in perfect condition.
Published by Springer Healthcare Ltd, 2014
ISBN 10: 1907673172 ISBN 13: 9781907673177
Language: English
Seller: Revaluation Books, Exeter, United Kingdom
Hardcover. Condition: Brand New. 1st edition. 273 pages. 7.75x5.00x0.75 inches. In Stock.
Published by Wien - New York, Springer,, 2005
ISBN 10: 3211262911 ISBN 13: 9783211262917
Language: English
Seller: COTTAGE Antiquariat - anbu.at, Langenzersdorf, Austria
4°, Original-Pappband. 141 Seiten. Illustriert. Exemplar noch originalverschweißt. Nahezu neuwertig. - in englischer Sprache. IS: 3211262911 ****An unsere Kunden in Deutschland: Versand nach Deutschland einmal in der Woche ab Freilassing mit der Deutschen Post.*** - Sprache: Englisch Gewicht in Gramm: 550.
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Condition: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Paperback. Condition: Brand New. reprint edition. 172 pages. 9.30x6.20x0.39 inches. In Stock.
Brand new book. Fast ship. Please provide full street address as we are not able to ship to P O box address.
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This mini-encyclopedia aims to provide a survey of the wide range of interventions available for treating schizophrenia at a level appropriate for non-specialists who are beginning their engagement in the area and for others as a source of reference for the specialist. The pharmacological options are considered alongside psychosocial management approaches and the advantages and disadvantages of each treatment modality are outlined. The entries are written by leading experts, including basic and clinical scientists in academia and industry, and include descriptions of many relevant fundamental psychological and biological processes of the disorder. The volume owes much to the Encyclopedia of Psychopharmacology edited by Ian Stolerman IP (published by Springer-Verlag in 2010), from which some entries are reproduced. Where entries deal with pharmacological interventions, the aim is to provide detailed information on the neuropsychopharmacology of the substances from domains such as clinical, experimental, and molecular pharmacology, insofar as they impact upon understanding of schizophrenia. Articles on non-drug interventions review the most recent evidence base related to commonly applied psychotherapeutic and rehabilitative measures. Other essays focus upon the key concepts and research methods used in the field, describing the main features of investigative techniques and outlining their roles, the types of information obtained and why they are needed; the advantages and limitations of a technique may also be summarized. The essays are complemented by many short definitions of important terms; in the interest of ease of reading, these definitions are not assigned to named authors; they are typically related to specific essays that they cross-reference and relevant authorship details can be found in the latter.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: As New. Unread book in perfect condition.
Condition: As New. Unread book in perfect condition.
Condition: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher.
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Condition: New.
Condition: New.
Condition: New. In.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Condition: New. In.
Condition: New.
Taschenbuch. Condition: Neu. Stroke-Vascular Diseases | David J. Brooks (u. a.) | Taschenbuch | Einband - flex.(Paperback) | Englisch | 2002 | Springer Vienna | EAN 9783211838662 | Verantwortliche Person für die EU: Springer-Verlag KG, Sachsenplatz 4-6, 1201 WIEN, ÖSTERREICH, productsafety[at]springernature[dot]com | Anbieter: preigu.
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Atherosclerosis, the underlying cause of heart attacks, strokes and peripheral vascular disease, is one of the major killers in the world. By 2020 WHO statistics indicate that it will be the most common cause of morbidity and mortality in both the industrialised world and the underdeveloped world. The disease develops slowly over many years in the innermost layer of large and medium-sized arteries (Fig. 1) (Scott, 1995; Ross, 1999; Naumova and Scott, 2000; Glass and Witztum, 2001; Libby, 2001). It does not usually become manifest before the fourth of fifth decade, but then often strikes with devas tating suddenness. Fifty per cent of individuals still die (25 per cent immedi ately) from their first heart attack; and morbidity from coronary heart disease and stroke is very significant. The disease has a profound impact on health care services and on industrial economies. The lesions of atherosclerosis Autopsy studies show that in humans atherosclerosis begins in the first and second decade of life. A similar disease can be produced in experimental animals, where diet and genetics can be manipulated to produce identical lesions. The earliest lesions are fatty streaks. These consist of an accumulation of lipid-engorged macrophages (foam cells) and T and B lymphocytes in the arterial intima. With time, the fatty streaks progress to intermediate lesions, composed of foam cells and smooth muscle cells.